Response and Resistance to Cladribine in Patients with advanced systemic Mastocytosis: A Registry-based Evaluation

J Lubke; N Naumann; S Kreil; G Metzgeroth; T Brand; HP Horny; Karl Sotlar; A Fabarius; P Valent; WK Hofmann; J Schwaab; A Reiter

Response and Resistance to Cladribine in Patients with advanced systemic Mastocytosis: A Registry-based Evaluation

J Lubke, N Naumann, S Kreil, G Metzgeroth, T Brand, HP Horny, Karl Sotlar, A Fabarius, P Valent, WK Hofmann, J Schwaab, A Reiter

Institute of Pathology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	23-23
Journal	Oncology Research and Treatment
Volume	45
Issue number	SUPPL 2
Publication status	Published - 2022

Cite this

@article{a5f50b530dd54deea593f88b86a3f5fb,

title = "Response and Resistance to Cladribine in Patients with advanced systemic Mastocytosis: A Registry-based Evaluation",

author = "J Lubke and N Naumann and S Kreil and G Metzgeroth and T Brand and HP Horny and Karl Sotlar and A Fabarius and P Valent and WK Hofmann and J Schwaab and A Reiter",

year = "2022",

language = "English",

volume = "45",

pages = "23--23",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "Karger ",

number = "SUPPL 2",

}

TY - JOUR

T1 - Response and Resistance to Cladribine in Patients with advanced systemic Mastocytosis: A Registry-based Evaluation

AU - Lubke, J

AU - Naumann, N

AU - Kreil, S

AU - Metzgeroth, G

AU - Brand, T

AU - Horny, HP

AU - Sotlar, Karl

AU - Fabarius, A

AU - Valent, P

AU - Hofmann, WK

AU - Schwaab, J

AU - Reiter, A

PY - 2022

Y1 - 2022

M3 - Abstract (Journal)

SN - 2296-5270

VL - 45

SP - 23

EP - 23

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - SUPPL 2

ER -